Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCTO.L Regulatory News (CTO)

  • There is currently no data for CTO

Trading Statement

25 Nov 2021 07:00

RNS Number : 5100T
TClarke PLC
25 November 2021
 

TClarke plc

 

TRADING UPDATE

 

TClarke plc ("TClarke" or the "Group"), the Building Services Group, today issues a trading update for the period from 1 July 2021 to date.

 

Trading Update

 

We are pleased to report that volumes have accelerated during the second half of the year as the Group implements its plan to achieve £500m revenue per annum by the end of 2023. As previously reported, revenue and profit for 2021 are heavily weighted to the last six months of the year, particularly in the London business, where revenue in the last quarter of 2021 is at a record high. Importantly, we are not experiencing any material shortages that impact our ability to meet delivery programmes on our projects.

As a result, the Group is pleased to report it continues to trade in line with expectations for the full year ending 31 December 2021.

Outlook and Order Book Growth

At 30 June 2021 we reported that the business had reached a significant strategic milestone with the forward order book in excess of £500m for the first time. At 31 October 2021 the forward order book had increased further to £525m; in excess of £320m as at that date (2020: £257m) was already secured for 2022 with many other significant opportunities in our bid pipeline.

As a result of the continued strength of the Group's forward order book and the proportion of the order book already secured for 2022, the Board now expects revenue for the year ended 31 December 2022 to be ahead of market expectations at £410m.

The Group has five key market sectors: Infrastructure, Residential & Hotels, Engineering Services, Technologies and Facilities Management. Technologies is a major growth area and key to achieving £500m. It is therefore pleasing to report that the Board now expects one third of Group revenues to come from Technologies in 2022, up from under 15% in 2020.

Our long-standing, high quality reputation and the strength of the relationships with our blue-chip clients is a key asset for TClarke. Furthermore, our strong balance sheet continues to be a significant differentiator and enables us to win and deliver projects of a scale which positions us well for further growth.

We approach the new financial year in a strong position, both operationally and financially which gives the Board confidence for the Group's prospects for delivering our £500m revenue target by the end of 2023.

 

Date: 25 November 2021

Ends

The information contained within this announcement is deemed by the Group to constitute inside information under the Market Abuse Regulations (EU) No.596/2014.

For further information contact:

TClarke plc

 

Mark Lawrence

 

Chief Executive Officer

Trevor Mitchell

Finance Director

 

 

Tel: 020 7997 7400

 

www.tclarke.co.uk

 

Cenkos Securities plc (Corporate Broker)

 

Ben Jeynes (Corporate Finance)

 

Alex Pollen (Sales)

 

Tel: 020 7397 8900

 

www.cenkos.com

RMS Partners

Simon Courtenay

Tel: 020 3735 6551

  

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPPGAUGUPGGMC
Date   Source Headline
29th Jun 20227:00 amRNSNotice of Investor Presentation
23rd Jun 202210:45 amRNSNotice of Results
22nd Jun 20222:46 pmRNSChange of Auditor
22nd Jun 20229:37 amRNSTotal Voting Rights
17th May 20227:00 amRNSTClarke to Present at Mello Investor Conference
11th May 202210:27 amRNSResult of AGM
11th May 20227:00 amRNSAGM Statement
10th May 202212:51 pmRNSESOT Share Purchase
5th May 20223:52 pmRNSESOT Share Purchase
3rd May 20229:03 amRNSDirector/PDMR Shareholding
26th Apr 20224:29 pmRNSVesting of EIP share awards April 2022
20th Apr 20229:27 amRNSChange of Registered Office
8th Apr 202210:09 amRNSPublication of Annual Report and Notice of AGM
8th Apr 20227:00 amRNSDirectorate Change
16th Mar 20228:27 amRNSDirector/PDMR Shareholding
16th Mar 20228:21 amRNSTotal Voting Rights
11th Mar 20227:00 amRNSInvestor Presentation
9th Mar 20227:02 amRNSDirectorate Change
9th Mar 20227:00 amRNSNotification of Investor Presentation
9th Mar 20227:00 amRNSFinal Results
2nd Feb 20223:21 pmRNSTotal Voting Rights
1st Feb 20227:00 amRNSNotification of Investor Presentation
27th Jan 20227:00 amRNSTrading Statement
4th Jan 202211:28 amRNSBlock listing Interim Review
9th Dec 20211:11 pmRNSESOT Share Purchase
6th Dec 20219:40 amRNSESOT Share Purchase
3rd Dec 202111:51 amRNSTR-1: Notification of Change of Holding
1st Dec 20213:02 pmRNSPDMR Disclosure
1st Dec 20213:00 pmRNSTotal Voting Rights and Share Capital
25th Nov 20217:00 amRNSTrading Statement
18th Oct 20217:00 amRNSInvestor Presentation
6th Oct 202111:14 amRNSPDMR Holding
6th Oct 202111:10 amRNSBlock Listing Application
22nd Sep 20217:00 amRNSNotice of Investor Presentation
17th Aug 20211:41 pmRNSDirector/PDMR Shareholding
9th Aug 20217:00 amRNSTClarke Selected for NHS Smart Buildings Framework
20th Jul 20217:00 amRNSHalf-year Report
5th Jul 20217:00 amRNSBlock listing Interim Review
1st Jul 20217:00 amRNSNotice of Results
1st Jul 20217:00 amRNSTotal Voting Rights
6th May 20219:04 amRNSTR-1: Notification of major holding in Company
5th May 202111:20 amRNSResult of AGM
5th May 20217:01 amRNSDirectorate Change
5th May 20217:00 amRNSAGM - Trading Update
29th Apr 20217:00 amRNSDirector / PDMR Shareholding
28th Apr 20217:00 amRNSDirector / PDMR Shareholding
12th Apr 202110:40 amRNSESOT Share Purchase
9th Apr 20212:53 pmRNSPublication of Annual Report & Notice of 2021 AGM
6th Apr 202110:39 amRNSESOT Share Purchase
26th Mar 20212:28 pmRNSESOT Share Purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.